CompletedNot Applicable

Permissive Intrapartum Glucose Control

United States96 participantsStarted 2022-10-05

Plain-language summary

The purpose of this study is to assess whether permissive intrapartum glycemic control compared to usual care would lead to similar rate of neonatal hypoglycemia among people with diabetes.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Singleton gestation * Presenting for intrapartum management (induction, labor, augmentation) * Any diagnosis of Type 1 Diabetes Mellitus(T1DM), Type 2 Diabetes Mellitus (T2DM), or Gestational Diabetes * English or Spanish fluency Exclusion Criteria: * Major fetal anomalies affecting glucose metabolism * Multiple Gestation * Incarcerated subjects * less than 34 weeks gestation of pregnancy * Planned cesarean delivery * Utilizing insulin pump during labor * Stillbirth * Presenting in Diabetic ketoacidosis(DKA)

What they're measuring

first neonatal blood glucose level measured in mg/dL

Timeframe: up to 2 hours of life prior to first feed

Trial details

NCT IDNCT05553275

SponsorThe University of Texas Health Science Center, Houston

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-02

View on ClinicalTrials.gov More Gestational Diabetes trials